Lynx Investment Advisory Astrazeneca PLC Transaction History
Lynx Investment Advisory
- $139 Billion
- Q3 2024
A detailed history of Lynx Investment Advisory transactions in Astrazeneca PLC stock. As of the latest transaction made, Lynx Investment Advisory holds 2,786 shares of AZN stock, worth $179,669. This represents 0.16% of its overall portfolio holdings.
Number of Shares
2,786
Previous 2,680
3.96%
Holding current value
$179,669
Previous $209 Million
3.85%
% of portfolio
0.16%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,349Shares Held
489MCall Options Held
5MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.19 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.71 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.62 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.37 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.14 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...